by Val Swisher | Jun 27, 2022
I want to spend a few minutes talking about three types of special statements found in most technical content: Notes Cautions Warnings Notes, cautions, and warnings are statements that serve a special purpose. They contain a sentence (or possibly two) that you want...
by Val Swisher | Jun 13, 2022
There are many reasons why a component structured content management (SCM) system is superior to using a Microsoft Word document for managing your Company Core Data Sheet (CDS or CCDS). We touched upon some of the reasons in our previous blog post, The CDS is Dead!...
by Val Swisher | Jun 6, 2022
The Company Core Data Sheet (CDS or CCDS) is one of the most important documents a pharmaceutical company creates. The CDS is a working document that contains information about the pharmaceutical product. It includes information from multiple sources, such as clinical...
by Val Swisher | May 24, 2022
In honor of the 28th anniversary of Content Rules, I have gone into my personal way back machine and selected four of my favorite posts from the Content Rules blog. The first post that we still have published is from April 23, 2010 and is about Mercury in Retrograde....
by Val Swisher | May 16, 2022
Raise your hand if you think content silos are ever going away. Yah. I didn’t raise mine either. After decades (literally) of talking about silos, calmly and not so calmly explaining to people why they are problematic, and advocating for their demise, I have come to...
by Regina Lynn Preciado | Apr 25, 2022
We talk a lot about the goal of enterprise content strategy for pharma: to help speed up the process of making safe, effective medicines. One part of achieving that goal is to get content through regulatory approval faster. To speed up review and approval, pharma...
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.